Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xinguan 2 + Xinguan 3
- Development stage
- Unknown
- Lead developer
- Hospital of Chengdu University of Traditional Chinese Medicine
- Administration
- Oral
01
Overview
Xinguan 2 and Xinguan 3 are traditional Chinese medicine (TCM) preparations developed by the Hospital of Chengdu University of Traditional Chinese Medicine for the treatment of COVID-19 (novel coronavirus pneumonia). These formulations were investigated in a real-world clinical study (ChiCTR2000030936) to evaluate their efficacy and safety when used alone or in combination with standard Western medical treatments. As botanical preparations, they are designed to leverage the multi-component, multi-target nature of TCM to potentially modulate the immune response and alleviate symptoms associated with viral pneumonia. Specific details regarding their herbal composition, active chemical constituents, and precise molecular targets have not been disclosed in public clinical registries.
- Other names
- Xinguan No. 2Xinguan No. 3
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))Mpro (3C-like proteinase of SARS-CoV-2)IL-6 (Interleukin 6)
Beyond the preview
Go deeper on Xinguan 2 + Xinguan 3.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xinguan 2 + Xinguan 3.